UK Stocks-Factors to watch on Feb. 10

Feb 10 (Reuters) - Britain's FTSE 100 .FTSE index is seen opening flat on Thursday, with futures FFIc1 up 0.03%.

* UNILEVER: Unilever ULVR.L forecast higher sales, but lower margins, for this year as it grapples with soaring inflation, and ruled out big acquisitions following recent investor criticism of its failed pursuit of GlaxoSmithKline's consumer health business.

* ASTRAZENECA: AstraZeneca AZN.L forecast higher 2022 sales and raised its annualised dividend after the drugmaker posted better-than-expected fourth-quarter profit.

* ASHMORE: Ashmore ASHM.L saw its pretax profit drop 23% in the six months to the end of 2021 as net outflows and poor investment performance hit the emerging markets investment firm's assets under management.

* RELX: Relx REL.L said it expected its 2022 underlying growth to be ahead of historical trends after a strong end to the year enabled it to hike its divided by 6% and launch a new buyback scheme.

* BEAZLEY: Insurer Beazley BEZG.L resumed its dividend after swinging to an annual profit, helped by rising demand and double-digit growth in the cyber insurance space.

* GSK-VIR: An antibody-based COVID-19 therapy developed by GSK GSK.L and Vir Biotechnology VIR.O retains neutralising activity against the emerging BA.2 form of the Omicron coronavirus variant.

* AB FOODS: Primark owner Associated British Foods ABF.L launched a 400 million pound 2.5% public bond due in 2034 to diversify the group's sources of funding and extend the duration of its borrowings.

* PRUDENTIAL: Prudential PRU.L said that its Chief Executive Officer Mike Wells would retire at the end of March this year.

* LEGAL & GENERAL: Legal & General LGEN.L has agreed a pensions buy-in deal totalling around 370 million pounds with London Heathrow's BAA Pension Scheme, L&G said.

* ILIAD-VODAFONE: French telecoms group Iliad has offered more than 11 billion euros to buy Vodafone's VOD.L Italian business, a source close to the matter said on Wednesday.

* UK's blue-chip index touched fresh two-year highs on Wednesday, joining a rally in global stock markets as investors cheered strong earnings while setting aside concerns about rising interest rates.

* For more on the factors affecting European stocks, please click on:


> Financial Times

> Other business headlines

Reporting by Amna Karimi in Bengaluru

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.